Volume
Open
Day's Low
Day's High
52 Wk Low
52 Wk High
Bid
Ask
EPS
PE Ratio
Shares
Market Cap
Dividend
Ex-Div Date
Yield
Bitcoin & Crypto Movers
Receive our Bitcoin / Cryptocurrency Reports, Free.
...
Health Technology » Biotechnology
| symbol | company | %chng | last | %short | avg$volume | |
|---|---|---|---|---|---|---|
| AMGN | Amgen Inc. | 0.00% | 205.10 | 1.2% | $477.70m | |
| GILD | Gilead Sciences, Inc. | 0.91% | 75.51 | 0.9% | $401.46m | |
| BIIB | Biogen Inc. | 1.22% | 345.41 | 1.3% | $352.23m | |
| CELG | Celgene Corporation | -0.66% | 87.72 | 1.2% | $341.18m | |
| ILMN | Illumina, Inc. | 0.52% | 358.16 | 3.5% | $248.76m | |
| REGN | Regeneron Pharmaceuticals, Inc. | 0.78% | 390.28 | 2.6% | $232.51m | |
| VRTX | Vertex Pharmaceuticals Incorporated | -0.24% | 180.08 | 1.9% | $168.98m | |
| EXAS | Exact Sciences Corporation | 1.72% | 76.28 | 25.3% | $162.68m | |
| SRPT | Sarepta Therapeutics, Inc. | -3.43% | 147.59 | 16.4% | $129.44m | |
| A | Agilent Technologies, Inc. | -0.58% | 70.72 | 1.5% | $124.93m | |
| VKTX | Viking Therapeutics, Inc. | -4.06% | 18.20 | 0.9% | $115.92m | |
| ALXN | Alexion Pharmaceuticals, Inc. | -2.10% | 121.99 | 2.0% | $114.40m | |
| NKTR | Nektar Therapeutics | 0.96% | 59.00 | 5.6% | $106.74m | |
| BMRN | BioMarin Pharmaceutical Inc. | -2.55% | 97.84 | 4.4% | $97.41m | |
| ALNY | Alnylam Pharmaceuticals, Inc | -0.67% | 94.57 | 9.7% | $93.14m |
Company Profile
Trillium Therapeutics Inc. is a clinical stage immuno-oncology company, which engages in the development of innovative therapies for the treatment of cancer. Its pipeline is comprised of TTI-621, TTI-622, and TTI-2341(EGFR Inhibitor). The company was founded on March 31, 2004 and is headquartered in Toronto, Canada.